查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
腎功能檢測市場 - 2018-2028 年全球行業規模、份額、趨勢、機遇和預測，按類型、組件、最終用戶和地區細分
市場調查報告書
商品編碼
1221590

腎功能檢測市場 - 2018-2028 年全球行業規模、份額、趨勢、機遇和預測，按類型、組件、最終用戶和地區細分

Kidney Function Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Component, By End User, By Region
出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

全球腎功能檢測市場預計到 2022 年將超過 8.62 億美元，到 2028 年將以 9.71% 的複合年增長率增長。

全球腎功能檢測市場的增長預計將受到腎功能診斷技術意識提高的支持。 糖尿病和高血壓是導致全球慢性腎髒病負擔不斷增加的主要原因。 在接下來的幾年裡，糖尿病患病率上升預計將影響市場擴張。 根據第 10 版國際糖尿病地圖集，估計到 2021 年，將有 5.37 億成年人（20-79 歲）或十分之一患有糖尿病。 預計到 2030 年將增加到 6.43 億，到 2045 年將增加到 7.83 億。 腎臟是人體最重要的器官之一。 腎臟充當血液過濾器，從血液中重新吸收必需元素並去除水溶性廢物。 因此，如果我們不通過再生死去的腎單位和維持適當的血液循環來維持健康的細胞增殖，我們就更有可能癌變和轉移。 腎功能不全在世界範圍內很常見，並且其發病率正在迅速增加。 與腎臟相關的症狀包括高血壓、尿液中的血液、排尿困難、尿頻以及由於積液導致的手腳腫脹。

腎臟疾病增加

獲得性囊性腎病、澱粉樣變性、糖尿病、異位腎病、腎小球疾病、抗GBM（Goodpasture）病和IgA腎病等腎臟疾病的增加需要準確的診斷和適當的治療。患者數量急劇增加. 預計這將推動全球腎功能檢測市場的增長。 此外，急性腎損傷 (AKI)，也稱為急性腎功能衰竭或急性腎損傷，是入院患者中非常常見的病症。 急性腎損傷 (AKI) 影響全世界超過 1300 萬人，每年導致 170 萬人死亡。 預計腎臟疾病和病症發病率的上升將增加對早期診斷和治療的需求，從而推動市場增長。 例如，根據美國疾病控制和預防中心 (CDC) 的數據，40% 的腎功能嚴重受損的人並不知道自己患有慢性腎病 (CKD)。

技術進步

在診斷和治療中越來越多地採用先進技術，預計將推動市場增長。 這些持續的發展和創新為患者提供了更好的治療。 最新的技術趨勢包括基於計算機的智能決策支持系統 (DSS) 和專家系統（用於透析並基於遺傳算法和人工神經網絡 (ANN)）。 此外，由於對 IoT（物聯網）的興趣日益濃厚，作為淺層 ANN 的擴展且複雜的深度學習正被用於醫療領域。 這些進步在診斷成像、警報系統和診斷輔助方面很有用。

糖尿病和高血壓患病率增加

糖尿病和高血壓等基礎疾病的增加顯著增加了對這些慢性病診斷和治療的需求。 預計這將對全球腎功能檢測市場的增長產生積極影響。 根據美國疾病控制與預防中心 (CDC) 的數據，2019 年將有大約 3730 萬糖尿病患者，占美國人口的 11.3%。 其中，有 2870 萬人確診，850 萬人未確診。 隨著人口老齡化，患糖尿病、高血壓等慢性病的風險增加，更容易患上腎病和腎功能衰竭。 由於這些慢性疾病會導致腎臟損害和衰竭，因此患有糖尿病和高血壓的老年人越來越多，這增加了對腎功能檢查的需求。 此外，糖尿病和高血壓患病率的增加正在增加慢性腎病 (CKD) 和急性腎損傷 (AKI) 患者的數量，從而推動市場增長。

近期發展

  • 2019 年，Fresenius Medical Care 憑藉其最先進的血液透析機獲得了美國 FDA 的突破性設備稱號，該機旨在不使用藥物即可停止血液凝固。
  • 同樣在 2019 年，CareDx 宣布了一種專為腎移植打造的新模型。 為患有慢性腎髒病 (CKD) 的人配備預測性人工智能 (AI)。
  • 最近，bioMerieux 於 2022 年獲得美國食品和藥物管理局 (U.S. FDA) 的批准，其創新的 VIDAS NEPHROCHECK 檢測方法可檢測有急性腎損傷 (AKI) 風險的個體的腎臟壓力。底部。

可自定義

TechSci Research 根據市場數據為公司的特定需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析。

內容

第 1 章概述

第2章研究方法論

第 3 章執行摘要

第4章客戶反饋

  • 腎臟疾病的流行：性別歧視
  • 腎病患病率（按年齡組劃分）
  • 患者對慢性腎病的認識
  • 常見腎臟疾病
  • 進行腎功能檢查時常用的物品

第 5 章腎功能檢測的全球市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型（尿液分析、血液測試）
    • 按成分（滴管、試劑、試劑盒和化驗、其他）
    • 由最終用戶（醫院/診所、診斷室等）
    • 按地區
  • 市場地圖
    • 按類型
    • 按組件
    • 最終用戶
    • 按地區

第6章北美腎功能檢測市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型
    • 按成分
    • 最終用戶
  • 按國家/地區劃分的北美市場分析
    • 美國
    • 加拿大
    • 墨西哥

第7章歐洲腎功能檢測市場前景

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型
    • 按成分
    • 最終用戶
    • 按地區
  • 歐洲國家分析
    • 法國
    • 德國
    • 英國
    • 荷蘭
    • 瑞典
    • 意大利
    • 西班牙

第 8 章亞太地區腎功能檢測市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型
    • 按成分
    • 最終用戶
    • 按地區
  • 亞太國家/地區分析
    • 中國
    • 日本
    • 新加坡
    • 印度
    • 韓國農業
    • 澳大利亞農業

第9章南美腎功能檢測市場展望

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型
    • 按成分
    • 最終用戶
    • 按地區
  • 南美分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲腎功能測試的市場前景

  • 市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按類型
    • 按成分
    • 最終用戶
    • 按地區
  • MEA：國家分析
    • 阿聯酋腎功能測試
    • 沙特阿拉伯的腎功能測試
    • 南非的腎功能測試

第 11 章市場動態

  • 司機
    • 腎臟疾病和疾病的患病率上升
    • 技術進步
    • 糖尿病和高血壓的增加
  • 任務
    • 嚴格的監管批准
    • 缺乏意識
    • 虛假識別報告

第12章新興國家市場趨勢與發展

  • 腎臟疾病的家庭診斷測試
  • 增加新的腎臟測試
  • 合作研究的增加

第13章競爭環境競爭格局

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
  • SWOT Analysis
    • Baxter International Inc
    • Abbott Laboratories, Inc.
    • Sysmex Corporation
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • URIT Medical Electronic Co. Ltd
    • Nova Biomedical Corporation
    • Laboratory Corporation of America Holdings
    • Siemens Healthineers
    • ARKRAY Inc.
    • IDEXX Laboratories, Inc
    • Fresenius SE & Co. KGaA
    • Cook Group
    • ACON Laboratories, Inc.
    • Randox Laboratories Ltd.

第14章 戰略建議

Product Code: 4585

Global kidney function tests market was valued over USD 862 million in 2022 and is forecast to grow at a CAGR of 9.71% through 2028. The growth of the global market for kidney function tests is anticipated to be supported by an increase in awareness of diagnostic techniques for kidney function. The growing global burden of chronic kidney disease is attributed in huge share to diabetes and high blood pressure. In the upcoming years, rising diabetes rates will have an effect on market expansion. The International Diabetes Atlas' tenth edition estimates that 537 million adults (20-79 years old), or one in ten people, had diabetes in 2021. It is anticipated that this number will increase to 643 million by 2030 and 783 million by 2045. Kidneys are among the most vital organs of the human body. Kidneys acts as blood filters, reabsorbing the essential elements and removing the water-soluble waste products from the blood. Hence, they require constant regeneration of dead nephrons and proper blood circulation to maintain healthy cell growth, otherwise they become vulnerable to cancerous tumors and metastasis. The functional damage of the kidney is common across the world and its incidents are increasing at a rapid pace. The symptoms which indicate a problem related to kidneys include high blood pressure, blood in urine, difficulty in urination, frequent urges to urinate, and swelling in the hands and feet due to a buildup of fluids in the body.

Rising Prevalence of Kidney Disorders and Diseases

The growing occurrence of several kidney disorders such as acquired cystic kidney disease, amyloidosis & kidney disease, diabetes insipidus, ectopic kidney, glomerular diseases, anti-GBM (Goodpasture's) disease, IgA nephropathy, among others have drastically increased the number of patients which requires accurate diagnosis and proper treatment. This, in turn, is expected to drive the growth of the global kidney function tests market. Furthermore, acute kidney injury (AKI), also known as acute renal failure or acute kidney injury, is very common in patients who are in hospitals. Acute kidney injury (AKI) affects more than 13 million people and results in 1.7 million deaths every year across the globe. Owing to the rising incidences of kidney diseases and disorders, the demand for early diagnosis and treatments is expected to surge, which bolsters the growth of the market. For instance, according to the Centers for Disease Control and Prevention (CDC), 40% of people with rigorously reduced kidney function are not aware of having chronic kidney disease (CKD).

Technological Advancements

Rising adoption of advanced technology concerning diagnosis and treatment is expected to bolster the growth of the market. These continuous developments and innovations are providing better treatments to patients. The latest trends in technology are using computer-based intelligent decision support systems (DSS) and expert systems, which are used in dialysis and are based on genetic algorithms and artificial neural networks (ANN). Also, the increase in interest in the internet of things (IoT), deep learning, an expanded and complex version of shallow ANN, is being used in the medical field. These advancements help in image diagnosis, alerting systems, and diagnostic assistance.

Increase in the Prevalence of Diabetes and Hypertension

The growing occurrences of underlying conditions such as diabetes and hypertension among the masses have significantly increased the demand for getting diagnoses and treatments done for these chronic diseases. This, in turn, is expected to positively influence the growth of the global kidney function tests market. According to the Centers for Disease Control and Prevention (CDC), in 2019, there are approximately 37.3 million people who have diabetes, accounting for 11.3% of the US population. Out of these, 28.7 million people are diagnosed, and 8.5 million people are undiagnosed. Rising geriatric population is more prone to kidney diseases and kidney failures as aging increases the risk of chronic diseases such as diabetes and hypertension. The increase in the number of elders suffering from diabetes and hypertension is surging the demand for kidney function tests, as kidney disorders and kidney failures are caused by these chronic diseases. Therefore, owing to the rising prevalence of diabetes and hypertension, there is a surge in the number of cases of Chronic Kidney Disease (CKD) and Acute Kidney Injury (AKI), which in turn, is facilitating the growth of the market.

Recent Developments

  • In 2019, Fresenius Medical Care received breakthrough device designation by the U.S. FDA for its most recent hemodialysis machine, whose objective is to stop blood clotting without using any medication
  • Similarly, in 2019, CareDx announced the new model built for kidney transplants. It has included Predicted artificial intelligence (AI) for individuals who are suffering from chronic kidney diseases (CKD).
  • Recently, in 2022, bioMerieux received United States Food and Drug Administration (US FDA) authorization for the innovative VIDAS NEPHROCHECK assay to detect kidney stress in individuals who are at risk of acute kidney injury (AKI).

Market Segmentation

Global kidney function tests market segmentation is based on type, component, end user, regional distribution, and competitional landscape. Based on type, the market is divided into urine tests, blood tests and others. Urine tests are further subcategorized into Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests. Blood tests are further categorized into Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests. Based on component, the market is categorized into Dipsticks, Reagents, Kits & Assays, and Others. Based on end user, the market is further bifurcated into Hospitals & Clinics, Diagnostic Laboratories, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising cases of renal disorders.

Market Players

Baxter International Inc., Abbott Laboratories, Inc., Sysmex Corporation., F. Hoffmann-La Roche Ltd., Danaher Corporation., URIT Medical Electronic Co. Ltd., Nova Biomedical Corporation., Laboratory Corporation of America Holdings., Siemens Healthineers., ARKRAY Inc., IDEXX Laboratories, Inc., Fresenius SE & Co. KGaA., Cook Group., ACON Laboratories, Inc, and Randox Laboratories Ltd. are some of the leading companies operating in the market.

Report Scope

In this report, global kidney function tests market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Kidney Function Tests Market, By Type:

Urine Tests

  • Urine Protein Tests
  • Creatinine Clearance Tests
  • Microalbumin Tests

Blood Tests

  • Serum Creatinine Tests
  • Glomerular Filtration Rate Tests
  • Blood Urea Nitrogen Tests

Others

  • Kidney Function Tests Market, By Component:

Dipsticks

Reagents

Kits & Assays

Others

  • Kidney Function Tests Market, By End User:

Hospitals & Clinics

Diagnostic Laboratories

Others

  • Kidney Function Tests Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • United Kingdom
  • Netherlands
  • Sweden
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • Singapore
  • India
  • South Korea
  • Australia

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • UAE
  • Saudi Arabia
  • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Kidney Function Tests market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Prevalence of Kidney Disorders, By Gender
  • 4.2. Prevalence of Kidney Disorders, By Age Group
  • 4.3. Patient's Awareness of Suffering From Chronic Kidney Disorder
  • 4.4. Commonly Observed Kidney Disorders
  • 4.5. Commonly Used Tests for Performing Kidney Function Tests

5. Global Kidney Function Tests Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Urine Tests and Blood Tests)
      • 5.2.1.1. By Urine Tests (Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests)
      • 5.2.1.2. By Blood Tests (Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests)
    • 5.2.2. By Component (Dipsticks, Reagents, Kits & Assays, Others)
    • 5.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
    • 5.2.4. By Region
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By Component
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Kidney Function Tests Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Component
    • 6.2.3. By End User
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Kidney Function Tests Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Component
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Kidney Function Tests Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Component
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Kidney Function Tests Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Component
        • 6.3.3.2.3. By End User

7. Europe Kidney Function Tests Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Component
    • 7.2.3. By End User
    • 7.2.4. By Region
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Kidney Function Tests Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Kidney Function Tests Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Kidney Function Tests Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By End User
    • 7.3.4. Netherlands Kidney Function Tests Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Component
        • 7.3.4.2.3. By End User
    • 7.3.5. Sweden Kidney Function Tests Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Component
        • 7.3.5.2.3. By End User
    • 7.3.6. Italy Kidney Function Tests Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Type
        • 7.3.6.2.2. By Component
        • 7.3.6.2.3. By End User
    • 7.3.7. Spain Kidney Function Tests Market Outlook
      • 7.3.7.1. Market Size & Forecast
        • 7.3.7.1.1. By Value
      • 7.3.7.2. Market Share & Forecast
        • 7.3.7.2.1. By Type
        • 7.3.7.2.2. By Component
        • 7.3.7.2.3. By End User

8. Asia-Pacific Kidney Function Tests Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Component
    • 8.2.3. By End User
    • 8.2.4. By Region
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Kidney Function Tests Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By End User
    • 8.3.2. Japan Kidney Function Tests Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By End User
    • 8.3.3. Singapore Kidney Function Tests Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By End User
    • 8.3.4. India Kidney Function Tests Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By End User
    • 8.3.5. South Korea Farming Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By End User
    • 8.3.6. Australia Farming Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Type
        • 8.3.6.2.2. By Component
        • 8.3.6.2.3. By End User

9. South America Kidney Function Tests Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Component
    • 9.2.3. By End User
    • 9.2.4. By Region
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Kidney Function Tests Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Kidney Function Tests Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Kidney Function Tests Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By End User

10. Middle East and Africa Kidney Function Tests Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Component
    • 10.2.3. By End User
    • 10.2.4. By Region
  • 10.3. MEA: Country Analysis
    • 10.3.1. UAE Kidney Function Tests Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Kidney Function Tests Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By End User
    • 10.3.3. South Africa Kidney Function Tests Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Components
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1. Rising Prevalence of Kidney Disorders and Diseases
    • 11.1.2. Technological Advancements
    • 11.1.3. Increase in the Prevalence of Diabetes and Hypertension
  • 11.2. Challenges
    • 11.2.1. Stringent Regulatory Approvals
    • 11.2.2. Lack of Awareness
    • 11.2.3. False Positive Report

12. Market Trends & Developments

  • 12.1. At-Home Diagnostic Test for Kidney Diseases
  • 12.2. Rise in New Kidney Tests
  • 12.3. Increasing Collaborations

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. Baxter International Inc
    • 13.6.2. Abbott Laboratories, Inc.
    • 13.6.3. Sysmex Corporation
    • 13.6.4. F. Hoffmann-La Roche Ltd
    • 13.6.5. Danaher Corporation
    • 13.6.6. URIT Medical Electronic Co. Ltd
    • 13.6.7. Nova Biomedical Corporation
    • 13.6.8. Laboratory Corporation of America Holdings
    • 13.6.9. Siemens Healthineers
    • 13.6.10. ARKRAY Inc.
    • 13.6.11. IDEXX Laboratories, Inc
    • 13.6.12. Fresenius SE & Co. KGaA
    • 13.6.13. Cook Group
    • 13.6.14. ACON Laboratories, Inc.
    • 13.6.15. Randox Laboratories Ltd.

14. Strategic Recommendations

List of Figures

List of Figures:

  • Figure 1: Global Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 2: Global Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 3: Global Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 4: Global Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 5: Global Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 6: Global Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 7: Global Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 8: Global Kidney Function Tests Market Share, By Company, By Value, 2022
  • Figure 9: Global Kidney Function Tests Market Map, By Type, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 10: Global Kidney Function Tests Market Map, By Urine Test, By Type, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 11: Global Kidney Function Tests Market Map, By Blood Test, By Type, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 12: Global Kidney Function Tests Market Map, By Component, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 13: Global Kidney Function Tests Market Map, By End User, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 14: Global Kidney Function Tests Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2022
  • Figure 15: North America Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 16: North America Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 17: North America Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 18: North America Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 19: North America Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 20: North America Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 21: North America Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 22: United States Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 23: New Cancer Cases Reported in the United States in 2020, Both Sexes, All Ages
  • Figure 24: United States Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 25: United States Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 26: United States Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 27: Canada Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 28: Total Health Research Expenditure in Canada (USD), 2017-2021
  • Figure 29: Canada Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 30: Canada Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 31: Canada Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 32: Mexico Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 33: Number of Kidney Transplants Performed in Mexico from 2018 to 2021(in 1,000s)
  • Figure 34: Mexico Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 35: Mexico Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 36: Mexico Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 37: Europe Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 38: Europe Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 39: Europe Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 40: Europe Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 41: Europe Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 42: Europe Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 43: Europe Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 44: France Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 45: Percentage of New Cancer Cases in France, Both Sexes, All Ages, 2020
  • Figure 46: France Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 47: France Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 48: France Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 49: Germany Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 50: Germany Research & Development Expenditure as a Percentage of GDP
  • Figure 51: Germany Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 52: Germany Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 53: Germany Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 54: United Kingdom Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 55: Annual Expenditure on Health in United Kingdom (USD Million), 2017-2021
  • Figure 56: United Kingdom Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 57: United Kingdom Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 58: United Kingdom Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 59: Netherlands Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 60: Total Number of Patients on the Kidney Transplant Waiting List in the Netherlands from 2019 to 2021
  • Figure 61: Netherlands Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 62: Netherlands Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 63: Netherlands Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 64: Sweden Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 65: Rate of Kidney Transplantation Activity Per Million Population in Sweden from 2019 to 2021
  • Figure 66: Sweden Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 67: Sweden Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 68: Sweden Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 69: Italy Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 70: Number of Individuals Suffering from Diabetes in Italy, 2017-2020 (In Thousands)
  • Figure 71: Italy Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 72: Italy Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 73: Italy Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 74: Spain Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 75: Percentage of New Cancer Cases in Spain, By Cancer Site, 2020
  • Figure 76: Spain Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 77: Spain Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 78: Spain Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 79: Asia-Pacific Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 80: Asia-Pacific Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 81: Asia-Pacific Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 82: Asia-Pacific Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 83: Asia-Pacific Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 84: Asia-Pacific Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 85: Asia-Pacific Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 86: China Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 87: Percentage of New Cancer Cases in China, Both Sexes, All Ages, 2020
  • Figure 88: China Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 89: China Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 90: China Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 91: Japan Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 92: Japan Research & Development Expenditure as a Percentage of GDP, 2017-2020
  • Figure 93: Japan Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 94: Japan Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 95: Japan Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 96: Singapore Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 97: Prevalence of Diseases in Singapore
  • Figure 98: Singapore Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 99: Singapore Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 100: Singapore Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 101: India Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 102: Share of Respondents with Diabetes across India (%), 2018-2021
  • Figure 103: India Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 104: India Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 105: India Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 106: South Korea Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 107: Percentage of New Cancer Cases in South Korea, Both Sexes, All Ages, 2020
  • Figure 108: South Korea Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 109: South Korea Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 110: South Korea Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 111: Australia Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 112: Australia Diabetes Estimates in People of Age Group 20-79 Years (in Thousands)
  • Figure 113: Australia Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 114: Australia Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 115: Australia Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 116: South America Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 117: South America Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 118: South America Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 119: South America Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 120: South America Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 121: South America Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 122: South America Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 123: Brazil Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 124: Governmental Health Expenditure in Brazil in 2021, By Area, (Square Unit)
  • Figure 125: Brazil Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 126: Brazil Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 127: Brazil Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 128: Argentina Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 129: Percentage of New Cancer Cases in Argentina, Both Sexes, All Ages, 2020
  • Figure 130: Argentina Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 131: Argentina Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 132: Argentina Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 133: Colombia Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 134: Percentage of New Cancer Cases in Colombia, Both Sexes, All Ages, 2020
  • Figure135: Colombia Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 136: Colombia Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 137: Colombia Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 138: Middle East & Africa Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 139: Middle East & Africa Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 140: Middle East & Africa Kidney Function Tests Market Share, By Urine Test, By Type, 2018-2028F
  • Figure 141: Middle East & Africa Kidney Function Tests Market Share, By Blood Test, By Type, 2018-2028F
  • Figure 142: Middle East & Africa Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 143: Middle East & Africa Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 144: Middle East & Africa Kidney Function Tests Market Share, By Region, By Value, 2018-2028F
  • Figure 145: UAE Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 146: Outpatient Healthcare Expenditure in UAE (USD Billion), 2017-2022
  • Figure 147: UAE Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 148: UAE Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 149: UAE Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 150: Saudi Arabia Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 151: Percentage of New Cancer Cases in Saudi Arabia, Both Sexes, All Ages, 2020
  • Figure 152: Saudi Arabia Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 153: Saudi Arabia Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 154: Saudi Arabia Kidney Function Tests Market Share, By End User, By Value, 2018-2028F
  • Figure 155: South Africa Kidney Function Tests Market Size, By Value (USD Million), 2018-2028F
  • Figure 156: Percentage of New Cancer Cases in South Africa, Both Sexes, All Ages, 2020
  • Figure 157: South Africa Kidney Function Tests Market Share, By Type, By Value, 2018-2028F
  • Figure 158: South Africa Kidney Function Tests Market Share, By Component, By Value, 2018-2028F
  • Figure 159: South Africa Kidney Function Tests Market Share, By End User, By Value, 2018-2028F